{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T19:26:05Z","timestamp":1778181965061,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T00:00:00Z","timestamp":1720396800000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018938","name":"Administration of Traditional Chinese Medicine of Jilin Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018938","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005892","name":"China Academy of Chinese Medical Sciences","doi-asserted-by":"publisher","award":["CI2022E021XB"],"award-info":[{"award-number":["CI2022E021XB"]}],"id":[{"id":"10.13039\/501100005892","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.heliyon.2024.e34329","type":"journal-article","created":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T14:06:52Z","timestamp":1720966012000},"page":"e34329","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comparison of different doses of Tripterygium glycosides treating in IgA vasculitis nephritis: A Bayesian network meta-analysis"],"prefix":"10.1016","volume":"10","author":[{"given":"Hui","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6967-1184","authenticated-orcid":false,"given":"Yanqin","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.heliyon.2024.e34329_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/art.37715","article-title":"Revised International chapel hill consensus conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e34329_bib2","first-page":"CD005128","article-title":"Interventions for preventing and treating kidney disease in Henoch-Sch\u00f6nlein Purpura (HSP)","author":"Chartapisak","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"issue":"8788","key":"10.1016\/j.heliyon.2024.e34329_bib3","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/0140-6736(92)91341-5","article-title":"Long-term follow-up of childhood Henoch-Sch\u00f6nlein nephritis","volume":"339","author":"Goldstein","year":"1992","journal-title":"Lancet"},{"issue":"4S","key":"10.1016\/j.heliyon.2024.e34329_bib4","article-title":"KDIGO 2021 clinical practice guideline for the management of glomerular diseases","volume":"100","year":"2021","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e34329_bib5","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00467-010-1741-5","article-title":"Treatment strategies for Henoch-Sch\u00f6nlein purpura nephritis by histological and clinical severity","volume":"26","author":"Ninchoji","year":"2011","journal-title":"Pediatr. Nephrol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e34329_bib6","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1097\/01.ASN.0000068460.37369.DC","article-title":"Treatment of IgA nephropathy with ACE inhibitors: a randomized and controlled trial","volume":"14","author":"Praga","year":"2003","journal-title":"J. Am. Soc. Nephrol. : JASN (J. Am. Soc. Nephrol.)"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e34329_bib7","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1631\/jzus.B1900607","article-title":"Use of Tripterygium wilfordii Hook F for immune-mediated inflammatory diseases: progress and future prospects","volume":"21","author":"Song","year":"2020","journal-title":"J. Zhejiang Univ. - Sci. B"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e34329_bib8","first-page":"1497","article-title":"Tripterygium for henoch-schonlein purpura nephritis in children: systematic review and meta analysis","volume":"34","author":"Wu","year":"2016","journal-title":"Chinese Archives of Traditional Chinese Medicine"},{"issue":"72","key":"10.1016\/j.heliyon.2024.e34329_bib9","first-page":"175","article-title":"Tripterygium for Henoch-Schonlein Purpura Nephritis in adult:a meta-analysis of randomized controlled trials","volume":"18","author":"Wang","year":"2018","journal-title":"World Latest Medicine Information"},{"key":"10.1016\/j.heliyon.2024.e34329_bib10","unstructured":"Liu, L., et al., Comparison of Different Doses of Tripterygium Glycosides Treating in Henoch-Sch\u00f6nlein Purpura Nephritis: a Bayesian Network Meta-Analysis. https:\/\/www.crd.york.ac.uk\/PROSPERO\/display_record.php?RecordID=401645. ."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e34329_bib11","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34329_bib12","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1186\/s13063-019-3484-3","article-title":"Traditional Chinese medicine versus regular therapy in Henoch-Sch\u00f6nlein purpura nephritis in children: study protocol for a randomized controlled trial","volume":"20","author":"Ding","year":"2019","journal-title":"Trials"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e34329_bib13","first-page":"246","article-title":"Experience of using Tripterygium wilfordii in the treatment of nephritis for 25 years","author":"Li","year":"2003","journal-title":"Chinese Journal of Nephrology, Dialysis & Transplantation"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e34329_bib14","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2215\/CJN.06710810","article-title":"Henoch-Schonlein purpura nephritis: pathophysiology, treatment, and future strategy","volume":"6","author":"Davin","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol. : CJASN"},{"issue":"13","key":"10.1016\/j.heliyon.2024.e34329_bib15","first-page":"2806","article-title":"Tripterygium glycosides in treatment of Henoch-Schonlein Purpura Nephritis:a systematic review of randomized controlled trials","volume":"43","author":"Wang","year":"2018","journal-title":"China J. Chin. Mater. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34329_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/adc.2004.066035","article-title":"Henoch schonlein purpura","volume":"93","author":"Tizard","year":"2008","journal-title":"Archives of Disease In Childhood. Education and Practice Edition"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e34329_bib17","first-page":"169","article-title":"Liver damage related to triptolide and its preparations: domestic literatures review and analysis","volume":"8","author":"Liang","year":"2011","journal-title":"Chinese Journal of Drug Application and Monitoring"},{"key":"10.1016\/j.heliyon.2024.e34329_bib18","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fphar.2018.00104","article-title":"A mechanistic overview of triptolide and celastrol, natural products from tripterygium wilfordii Hook F","volume":"9","author":"Chen","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e34329_bib19","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.tox.2015.07.008","article-title":"Triptolide disrupts fatty acids and peroxisome proliferator-activated receptor (PPAR) levels in male mice testes followed by testicular injury: a GC-MS based metabolomics study","volume":"336","author":"Ma","year":"2015","journal-title":"Toxicology"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e34329_bib20","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1440-1681.2011.05586.x","article-title":"Tripterygium wilfordii bioactive compounds as anticancer and anti-inflammatory agents","volume":"39","author":"Wong","year":"2012","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.heliyon.2024.e34329_bib21","first-page":"1","article-title":"Network meta-analysis of efficacy of six Chinese patent medicines combined with western medicine in the treatment of henoch-schonlein purpura nephritis in children","author":"Zhang","year":"2022","journal-title":"Pharmacology and Clinics of Chinese Materia Medica"},{"key":"10.1016\/j.heliyon.2024.e34329_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2019.112442","article-title":"Advances in anti hepatic fibrotic therapy with Traditional Chinese Medicine herbal formula","volume":"251","author":"Li","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.heliyon.2024.e34329_bib23","series-title":"Tripterygium Glycosides Combined with Glucocorticoid in the Treatment of Henoch-Schonlein Purpura Nephritis: a Systematic Review and Meta-Analysis","author":"Wang","year":"2019"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e34329_bib24","first-page":"339","article-title":"Meta-analysis of blood system adverse events of Tripterygium wilfordii","volume":"40","author":"Li","year":"2015","journal-title":"China J. Chin. Mater. Med."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e34329_bib25","first-page":"2357","article-title":"Analysis of adverse drug reaction of glucoside tripterygium total","volume":"24","author":"Jiang","year":"2009","journal-title":"West China Med. J."},{"key":"10.1016\/j.heliyon.2024.e34329_bib26","series-title":"Proceedings of the Seventh National Toxicology Conference of China Toxicology Association and the Eighth Hubei Science and Technology Forum","first-page":"130","article-title":"Study on toxicity of tripterygium glycosides to digestive tract","author":"Yang","year":"2015"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402410360X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402410360X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T13:51:11Z","timestamp":1773841871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240584402410360X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":26,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S240584402410360X"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34329","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of different doses of Tripterygium glycosides treating in IgA vasculitis nephritis: A Bayesian network meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34329","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e34329"}}